GPT Healthcare Limited (NSE:GPTHEALTH)
164.60
-0.29 (-0.18%)
Apr 24, 2025, 12:31 PM IST
GPT Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2016 - 2019 |
Revenue | 4,051 | 4,002 | 3,610 | 3,374 | 2,428 | 2,118 | Upgrade
|
Revenue Growth (YoY) | 2.08% | 10.85% | 7.00% | 39.00% | 14.59% | 23.26% | Upgrade
|
Cost of Revenue | 1,644 | 1,648 | 1,511 | 1,534 | 1,075 | 882.25 | Upgrade
|
Gross Profit | 2,407 | 2,354 | 2,100 | 1,840 | 1,352 | 1,236 | Upgrade
|
Selling, General & Admin | 59.97 | 59.97 | 65.87 | 42.12 | 23.47 | 29.7 | Upgrade
|
Other Operating Expenses | 1,466 | 1,394 | 1,290 | 1,058 | 826.25 | 834.56 | Upgrade
|
Operating Expenses | 1,733 | 1,651 | 1,505 | 1,236 | 977.75 | 986.85 | Upgrade
|
Operating Income | 674.14 | 703.45 | 594.4 | 604.51 | 374.55 | 249.34 | Upgrade
|
Interest Expense | -34.38 | -64.95 | -84.43 | -101.94 | -127.63 | -125.17 | Upgrade
|
Interest & Investment Income | 36.04 | 36.04 | 38.8 | 39.73 | 39.39 | 36.35 | Upgrade
|
Other Non Operating Income (Expenses) | 31 | -1.22 | -2.98 | -5.91 | -5.45 | -11.14 | Upgrade
|
EBT Excluding Unusual Items | 706.79 | 673.32 | 545.79 | 536.39 | 280.86 | 149.38 | Upgrade
|
Gain (Loss) on Sale of Investments | 2.9 | 2.9 | 1.79 | 1.93 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -2.03 | -2.03 | 4.51 | -1.14 | 6.48 | -2.14 | Upgrade
|
Asset Writedown | 1.01 | 1.01 | - | 1.13 | -9.36 | - | Upgrade
|
Other Unusual Items | 5.24 | 5.24 | 7.61 | 2.48 | 10.85 | 1.15 | Upgrade
|
Pretax Income | 713.91 | 680.43 | 559.69 | 540.79 | 288.83 | 148.39 | Upgrade
|
Income Tax Expense | 215.43 | 202.74 | 169.62 | 124.16 | 77.9 | 38.83 | Upgrade
|
Net Income | 498.48 | 477.69 | 390.08 | 416.63 | 210.93 | 109.56 | Upgrade
|
Net Income to Common | 498.48 | 477.69 | 390.08 | 416.63 | 210.93 | 109.56 | Upgrade
|
Net Income Growth | 2.52% | 22.46% | -6.37% | 97.52% | 92.53% | -26.73% | Upgrade
|
Shares Outstanding (Basic) | 82 | 80 | 80 | 80 | 80 | 80 | Upgrade
|
Shares Outstanding (Diluted) | 82 | 80 | 80 | 80 | 80 | 80 | Upgrade
|
Shares Change (YoY) | 2.19% | 0.24% | - | - | - | - | Upgrade
|
EPS (Basic) | 6.10 | 5.96 | 4.88 | 5.21 | 2.64 | 1.37 | Upgrade
|
EPS (Diluted) | 6.10 | 5.96 | 4.88 | 5.21 | 2.64 | 1.37 | Upgrade
|
EPS Growth | 0.29% | 22.13% | -6.33% | 97.36% | 92.69% | -26.74% | Upgrade
|
Free Cash Flow | - | 494.25 | 565.24 | 586.96 | 369.46 | -55.82 | Upgrade
|
Free Cash Flow Per Share | - | 6.17 | 7.07 | 7.35 | 4.62 | -0.70 | Upgrade
|
Dividend Per Share | 2.500 | 2.500 | 4.000 | - | 6.000 | 1.500 | Upgrade
|
Dividend Growth | - | -37.50% | - | - | 300.00% | - | Upgrade
|
Gross Margin | 59.41% | 58.83% | 58.16% | 54.55% | 55.71% | 58.35% | Upgrade
|
Operating Margin | 16.64% | 17.58% | 16.46% | 17.92% | 15.43% | 11.77% | Upgrade
|
Profit Margin | 12.31% | 11.94% | 10.80% | 12.35% | 8.69% | 5.17% | Upgrade
|
Free Cash Flow Margin | - | 12.35% | 15.66% | 17.40% | 15.22% | -2.63% | Upgrade
|
EBITDA | 804.91 | 831.82 | 715.61 | 724.06 | 491.33 | 351.68 | Upgrade
|
EBITDA Margin | 19.87% | 20.79% | 19.82% | 21.46% | 20.24% | 16.60% | Upgrade
|
D&A For EBITDA | 130.78 | 128.37 | 121.21 | 119.55 | 116.78 | 102.34 | Upgrade
|
EBIT | 674.14 | 703.45 | 594.4 | 604.51 | 374.55 | 249.34 | Upgrade
|
EBIT Margin | 16.64% | 17.58% | 16.46% | 17.92% | 15.43% | 11.77% | Upgrade
|
Effective Tax Rate | 30.18% | 29.80% | 30.30% | 22.96% | 26.97% | 26.17% | Upgrade
|
Revenue as Reported | 4,136 | 4,055 | 3,667 | 3,424 | 2,489 | 2,161 | Upgrade
|
Advertising Expenses | - | 41.43 | 50.5 | 26 | 12.87 | 19.06 | Upgrade
|
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.